Blogs

Advocating to MACs on behalf of your patients

In light of newly published fee schedules that include low payment rates for LipiFlow, Cynthia Matossian, MD, FACS, ABES, advises on how eyecare professionals should advocate for their patients and practices.

What is happening with LipiFlow reimbursement?

Cynthia Matossian, MD, FACS, ABES, takes a look at the recent, sudden change in low-payment reimbursement by Medicare Administrative Contractors for LipFlow and MGD procedure codes.

Scattered routines have ocular surface consequences

Increased time on digital devices and erratic schedules have disrupted patients’ management of their MGD and dry eye disease.

The MGD patient journey: maintenance over time

January 21, 2021

Cynthia Matossian, MD, FACS, ABES, continues her discussion on MGD treatment by explaining why it's important for patients to understand that MGD and dry eye are lifelong, chronic conditions requiring regular maintenance and monitoring.

The MGD patient journey: diagnosis + initial treatment

January 09, 2021

Cynthia Matossian, MD, FACS, ABES, discusses the big disconnect between signs and symptoms of ocular surface disease, including meibomian gland dysfunction, and why a clear process for educating patients and initiating treatment is essential.